Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study
Conclusion: The preoperative CRP/Alb ratio is a strong prognostic factor for PDAC patients with undergo curative resection with S-1 adjuvant chemotherapy.
Source: In Vivo - Category: Research Authors: MURAKAWA, M., YAMAMOTO, N., KAMIOKA, Y., KAMIYA, M., KOBAYASHI, S., UENO, M., MORIMOTO, M., ATSUMI, Y., AOYAMA, T., TAMAGAWA, H., YUKAWA, N., RINO, Y., MASUDA, M., MORINAGA, S. Tags: Clinical Studies Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Pancreas | Pancreatic Cancer | Research | Study